tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Axsome Therapeutics’ Earnings Call Highlights Robust Growth
PremiumCompany AnnouncementsAxsome Therapeutics’ Earnings Call Highlights Robust Growth
28d ago
Axsome Therapeutics price target raised to $176 from $173 at BofA
Premium
The Fly
Axsome Therapeutics price target raised to $176 from $173 at BofA
28d ago
Axsome Therapeutics Reports Strong Q2 2025 Growth
Premium
Company Announcements
Axsome Therapeutics Reports Strong Q2 2025 Growth
28d ago
Axsome Therapeutics: Strong Financial Performance and Strategic Advancements Reinforce Buy Rating
PremiumRatingsAxsome Therapeutics: Strong Financial Performance and Strategic Advancements Reinforce Buy Rating
29d ago
Axsome Therapeutics Reports Strong Q2 2025 Performance
Premium
Company Announcements
Axsome Therapeutics Reports Strong Q2 2025 Performance
29d ago
Axsome Therapeutics reports Q2 EPS (97c), consensus ($1.09)
Premium
The Fly
Axsome Therapeutics reports Q2 EPS (97c), consensus ($1.09)
29d ago
Buy Rating for Axsome Therapeutics: Late-Stage Pipeline and Growth Potential
PremiumRatingsBuy Rating for Axsome Therapeutics: Late-Stage Pipeline and Growth Potential
1M ago
Axsome Therapeutics: Promising Growth Driven by Robust Pipeline and Strategic Fit
Premium
Ratings
Axsome Therapeutics: Promising Growth Driven by Robust Pipeline and Strategic Fit
1M ago
Axsome Therapeutics’ Promising Pipeline and Growth Potential Justifies Buy Rating
Premium
Ratings
Axsome Therapeutics’ Promising Pipeline and Growth Potential Justifies Buy Rating
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100